Brief: RaQualia Pharma signs license agreement with Maruho on selective Na sodium channel blocker

RaQualia Pharma

25/12/2017 07:24

Dec 25 (Reuters) - RaQualia Pharma Inc  4579.T  : 
       
    * Says it and Maruho Co Ltd planed to enter into license 
agreement, regarding selective Na sodium channel blocker, on 
Dec. 25 
 
     
    Source text in Japanese: https://goo.gl/BGxe44 
    Further company coverage: 4579.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))